We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFX
3251
DELISTED
BowFlex Inc.
BFX
$2.36M ﹤0.01%
176,690
+98,022
+125% +$1.42M
DLR icon
3252
CALL
Digital Realty Trust
DLR
$74.1B
$2.36M ﹤0.01%
20,700
-29,900
-59% -$3.52M
IEZ icon
3253
iShares US Oil Equipment & Services ETF
IEZ
$393M
$2.35M ﹤0.01%
65,544
-6,042
-8% -$204K
KEY icon
3254
PUT
KeyCorp
KEY
$25B
$2.35M ﹤0.01%
116,700
+9,900
+9% +$187K
AVEO
3255
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.35M ﹤0.01%
+84,382
New +$2.62M
NJR icon
3256
New Jersey Resources
NJR
$5.64B
$2.35M ﹤0.01%
58,539
-306,676
-84% -$13.2M
PETS icon
3257
CALL
PetMed Express
PETS
$39.5M
$2.35M ﹤0.01%
51,700
-37,200
-42% -$1.47M
IPAY icon
3258
Amplify Mobile Payments ETF
IPAY
$188M
$2.35M ﹤0.01%
67,319
+21,068
+46% +$717K
MIDD icon
3259
PUT
Middleby
MIDD
$5.33B
$2.35M ﹤0.01%
17,400
+6,800
+64% +$832K
EBIX
3260
DELISTED
Ebix Inc
EBIX
$2.35M ﹤0.01%
29,626
-32,043
-52% -$2.33M
EXP icon
3261
CALL
Eagle Materials
EXP
$6.4B
$2.35M ﹤0.01%
20,700
-14,900
-42% -$1.61M
LJPC
3262
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.34M ﹤0.01%
72,800
+59,600
+452% +$1.95M
JILL icon
3263
J. Jill
JILL
$283M
$2.34M ﹤0.01%
71,529
-59,323
-45% -$1.65M
MBI icon
3264
PUT
MBIA
MBI
$264M
$2.34M ﹤0.01%
319,800
+237,200
+287% +$1.84M
VPL icon
3265
Vanguard FTSE Pacific ETF
VPL
$8.64B
$2.34M ﹤0.01%
32,106
+20,791
+184% +$1.48M
RGS icon
3266
Regis Corp
RGS
$69.3M
$2.34M ﹤0.01%
7,616
-1,457
-16% -$447K
TEN
3267
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$2.34M ﹤0.01%
39,945
-34,461
-46% -$2.04M
BOJA
3268
DELISTED
Bojangles', Inc. Common Stock
BOJA
$2.33M ﹤0.01%
197,665
+89,777
+83% +$1.13M
NE
3269
PUT
DELISTED
Noble Corporation
NE
$2.33M ﹤0.01%
515,700
-118,800
-19% -$492K
FIVN icon
3270
FIVE9
FIVN
$2.47B
$2.33M ﹤0.01%
93,650
+30,418
+48% +$750K
MTN icon
3271
Vail Resorts
MTN
$5.28B
$2.33M ﹤0.01%
10,969
+3,399
+45% +$761K
ROCK icon
3272
Gibraltar Industries
ROCK
$1.42B
$2.33M ﹤0.01%
70,561
+11,394
+19% +$364K
WBC
3273
PUT
DELISTED
WABCO HOLDINGS INC.
WBC
$2.33M ﹤0.01%
16,200
+11,000
+212% +$1.62M
CRTO icon
3274
PUT
Criteo S.A.
CRTO
$931M
$2.32M ﹤0.01%
89,300
-59,400
-40% -$2.13M
IPHS
3275
DELISTED
Innophos Holdings, Inc.
IPHS
$2.32M ﹤0.01%
49,745
-6,453
-11% -$301K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.